Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Genesco Expects FY25 Sales Decline Of (1)%-(2)% (Prior (2)%-(3)%); Reiterated EPS of $0.60 - $1.00 Vs. $0.81 Est.

Author: Benzinga Newsdesk | September 06, 2024 06:55am

Fiscal 2025 Outlook

For Fiscal 2025, the Company:

  • Now expects total sales to decrease 1% to 2% compared to Fiscal 2024, or flat to down 1% excluding the 53rd week in Fiscal 2024 versus prior expectations for a total sales decrease of 2% to 3%, or down 1% to 2% excluding the 53rd week in Fiscal 2024
  • Continues to expect adjusted diluted earnings per share from continuing operations in the range of $0.60 to $1.00 
  • Guidance assumes no further share repurchases and a tax rate of 27%

Posted In: GCO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist